ctrl K

Price Alert

Adaptive Biotechnologies ... (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

12.43

-0.61 (-4.68%)

At close: Aug 18, 2025, 3:59 PM

12.47

0.32%

After-hours: Aug 18, 2025, 07:37 PM EDT

Adaptive Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	178.96M	170.28M	185.31M	154.34M
Cost of Revenue	72.08M	75.55M	57.91M	49.3M
Gross Profit	106.88M	94.72M	127.4M	105.04M
Operating Income	-162.55M	-227.03M	-200.19M	-208.97M
Interest Income	14.53M	15.53M	4.06M	1.67M
Pretax Income	-159.59M	-225.3M	-200.37M	-207.3M
Net Income	-159.49M	-225.25M	-142.46M	-205.61M
Selling & General & Admin	157.56M	172.51M	184.13M	169.97M
Research & Development	102.95M	122.12M	141.76M	142.34M
Other Expenses	8.91M	27.13M	1.7M	1.7M
Operating Expenses	269.43M	321.76M	327.58M	314.01M
Interest Expense	11.58M	13.8M	4.24M	n/a
Selling & Marketing Expenses	84.76M	88.58M	95.6M	95.47M
Cost & Expenses	341.51M	397.31M	385.49M	363.31M
Income Tax Expense	n/a	n/a	-57.9M	-1.69M
Shares Outstanding (Basic)	147.1M	144.38M	142.52M	140.35M
Shares Outstanding (Diluted)	147.1M	144.38M	142.52M	140.35M
EPS (Basic)	-1.08	-1.56	-1	-1.46
EPS (Diluted)	-1.08	-1.56	-1	-1.46
EBITDA	-128.76M	-189.27M	-167.98M	-193.34M
EBIT	-148.01M	-211.5M	-196.13M	-207.3M
Depreciation & Amortization	19.26M	22.23M	28.15M	20.98M